직장 결장암의 간전이 환자에서 VEGF-A, C, D 발현의 비교연구

다국어 초록 (Multilingual Abstract)

Purpose: We aimed to investigate the correlations between expressions of angiogenic cytokines VEGF-A, C, D of primary colorectal cancer and liver metastasis.
Methods: We examined paraffin-embedded primary colorectal cancer tissue from 45 patients who had liver resection due to colorectal liver metastasis (metastasis group) and 37 patients who had surgical resection due to colorectal cancer only (control group). In the control group, local recurrence and distant metastasis had not occurred. Immunohistochemical staining for VEGF-A, C and D was performed. We analysed the correlations between expression of VEGF-A, C and D in primary colorectal cancer tissues and clinicopathologic parameters.
Results: VEGF-A expressions of primary colorectal carcinoma were not different between the two groups. VEGF-C was more frequently expressed in the metastasis group (P=0.008) but VEGF-D was more expressed in the control group (P=0.003). Patients with VEGF-C negative and VEGF-D positive expression were predominant in the control group (P=0.020). Tumor location, T stage, lymph node metastasis and tumor differentiation were not related with the expressions of VEGF-A, C, D but only preoperative CEA was positively correlated with VEGF-A and C expression.
Conclusion: Expressions of VEGF-C in primary tumor were more frequent in metastatic colorectal cancer and expressions of VEGF-D were more frequent in nonmetastatic colorectal cancer. More large-scale prospective studies for VEGF-C and D expression in colorectal cancer are necessary.

목차 (Table of Contents)

• 서론
• 방법
• 결과
• 고찰
• 결론
• REFERENCES

참고문헌 (Reference)

1 Folkman J, "What is the evidence that tumors are angiogenesis dependent?" 82 : 4-6, 1990

2 Dvorak HF, "Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis" 146 : 1029-1039, 1995

3 Salven P, "Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors" 153 : 103-108, 1998

4 Amioka T, "Vascular endothelial growth factor-C expression predicts lymph node metastasis of human gastric carcinomas invading the submucosa" 38 : 1413-1419, 2002

5 Akagi K, "Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues" 83 : 887-891, 2000

6 Peters KG, "Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth" 90 : 8915-8919, 1993

7 Achen MG, "Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)" 95 : 548-553, 1998

8 Veikkola T, "VEGFs, receptors and angiogenesis" 9 : 211-220, 1999

9 George ML, "VEGF-A, VEGF-C, and VEGF-D in colorectal cancer progression" 3 : 420-427, 2001

10 Folkman J, "Tumor angiogenesis: therapeutic implications" 285 : 1182-1186, 1971

11 Cheung N, "Tissue-specific expression pattern of vascular endothelial growth factor isoforms in the malignant transformation of lung and colon" 29 : 910-914, 1998

12 Houck KA, "The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA" 5 : 1806-1814, 1991

13 Tischer E, "The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing" 266 : 11947-11954, 1991

14 Park JK, "Prognostic factors affecting survival rate following hepatic resection for metastatic colorectal cancer" 61 : 583-587, 2001

15 Yang Y, "P53 mutations in primary tumors and subsequent liver metastases are related to survival in patients with colorectal carcinoma who undergo liver resection" 91 : 727-736, 2001

16 Stacker SA, "Lymphangiogenesis and cancer metastasis" 2 : 573-583, 2002

17 Jenkins LT, "Hepatic resection for metastatic colorectal cancer" 63 : 605-610, 1997

18 Niki T, "Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma" 6 : 2431-2439, 2000

19 Cascinu S, "Expression of vascular endothelial growth factor can predict event-free survival in stage II colon cancer" 6 : 2803-2807, 2000

20 Kaipainen A, "Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development" 92 : 3566-3570, 1995

21 Onogawa S, "Expression of VEGF-C and VEGF-D at the invasive edge correlates with lymph node metastasis and prognosis of patients with colorectal carcinoma" 95 : 32-39, 2004

22 Kitadai Y, "Clinicopathological significance of vascular endothelial growth factor (VEGF)-C in human esophageal squamous cell carcinomas" 93 : 662-666, 2001

23 Furudoi A, "Clinical significance of vascular endothelial growth factor C expression and angiogenesis at the deepest invasive site of advanced colorectal carcinoma" 62 : 157-166, 2002

24 De Jong KP, "Clinical relevance of transforming growth factor alpha, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors" 28 : 971-979, 1998

25 Stacker SA, "Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers" 274 : 32127-32136, 1999

26 Joukov V, "A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases" 15 : 290-298, 1996